Alligator Bioscience
0.91 SEK +1.11%2 investors are following this company
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Revenue
58.11M
EBIT %
-428.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
ATORX
Daily low / high price
0.891 / 0.929
SEK
Market cap
690.68M SEK
Turnover
724.79K SEK
Volume
800K
Latest videos
Financial calendar
Interim report
06.05.2024
General meeting
07.05.2024
Interim report
11.07.2024
Interim report
24.10.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Allegro Investment | 31.2 % | 31.3 % |
Roxette Photo | 8.1 % | 8.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Change in number of shares and votes in Alligator Bioscience AB
Alligator Bioscience and Orion Corporation announce exercise of development option under 2021 Immuno-oncology Research Collaboration and License Agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools